WhatsApp Group Join Now
WhatsApp Channel Join Now
Telegram Group Join Now
HomeAndhra PradeshGland Pharma walk-in interview for Quality Control on 26th Dec 2024

Gland Pharma walk-in interview for Quality Control on 26th Dec 2024

Gland Pharma has expanded significantly from its origins as a contract manufacturer of small volume liquid parenteral products. It has evolved into a leading injectable-focused company, with a strong presence in 60 countries worldwide, such as the United States, Europe, Canada, Australia, India, and other key markets. Our operations are predominantly conducted through a business to business (B2B) framework, and we have a proven history of success in the intricate process of developing, manufacturing, and promoting complex injectables.

Greetings from Gland Pharma Limited!!!

Gland Pharma Limited invites you to a walk-in interview for QC positions on December 26, 2024. Bring your expertise in HPLC, GC, and relevant qualifications. Explore career opportunities at Gland Pharma Limited! Attend our walk-in interview for QC roles on December 26, 2024, and showcase your skills in analytical techniques.

Walk-In Interview for QC Department – API on Thursday (26/12/2024) at Gland Pharma Ltd, JNPC, Parawada.

Department: Quality Control
Role: Chemist / Junior Executive
Experience: 2 to 5 Years of relevant experience
Qualification: M.Sc. / B. Pharma
Work Location: Parawada.
Required Skills: Hands on experience in HPLC, GC, GC-MS & UV

Walk-in interview details
Date of interview: 26th December 2024 (Thursday)
Time: 09:00 AM to 11:30 AM
Address: Gland Pharma Limited, Plot No. 49&50, JN Pharmacity, Parawada, Visakhapatnam – 531019.

0/5 (0 Reviews)

Discover more from Pharma Walks

Subscribe to get the latest posts sent to your email.

RELATED JOBS

Join us

3,654FansLike
5,353FollowersFollow
4,233FollowersFollow
9,843SubscribersSubscribe

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Discover more from Pharma Walks

Subscribe now to keep reading and get access to the full archive.

Continue reading